Agenda

RISE UP Conference Agenda

November 1-3, 2024

 

Friday, November 1, 2024

Welcome & Keynote Address (12:00 pm to 12:30 pm): A Paradigm Shift in Women’s health: A Holistic View of hormone cycle control and breast cancer risk reduction

Keynote Address: The Launch of the Birth Control Pill and How It Should Inform Decisions Today  (Liz Watkins) 

General Session #1 (12:30 pm to 2:00 pm): The role of tumor classification in optimizing therapy and outcomes

Session Chairs: Laura Van ‘T Veer, Lajos Pusztai

Advocate: Amy Delson 

  • Presented Abstracts: Tumor classifiers and targeted therapeutics
  • Summary: Lessons learned about what reduces breast cancer progression and for whom                                          

General Session #2 (2:15 pm to 3:45 pm): Imaging as a predictive biomarker in clinical trials early endpoint

Session Chairs: Elissa Price, Nola Hylton

Advocates: Jan Tomlinson & Diane Heditsian 

  • Presented Abstracts: Imaging Endpoints
  • Summary: New tools that are modifiable and that can be used as trial end points

General Session #3 (4:00 pm to 6:15 pm): Increasing efficacy while decreasing toxicity of local and systemic therapy

Session Chairs: Hope Rugo, Silvia Formenti

  • Debate #1: De-escalation of local therapy
  • Debate #2: Is pCR enough to stop systemic therapy? (pro/con)
  • Presented Abstracts: New Concepts to reduce toxicity

Poster Session #1 (6:30 pm to 7:30 pm): Tumor classifiers, imaging endpoints, toxicity reduction

Saturday, November 2, 2024

General Session #4 (8:00 am to 9:30 am): Risk Prediction and Biomarkers for Prevention Trials

Session Chairs: Laura Fejerman, Adetunji (Tunji) Toriola

Advocate: Carmelita Austin-Schreher 

  • Presented Abstracts: Risk Factors and risk prediction; Impact of environmental exposures/disparities in breast cancer risk/outcomes

General Session #5 (9:35 am to 11:30 am): Applying the lessons of breast cancer biology to prevention      

Session Chairs: Carol Fabian, Andrea DeCensi

Advocate: Noelle Karmo

  • Exciting Agents for prevention (Dr. Barry Komm and Dr. Stephen Hursting)
  • Presented Abstracts: Prevention Trials in Progress

Poster Session #2 (11:30 am to 1:15 pm): Prevention studies in progress, Turnaway study, etc.

General Session #6 (2:15 pm to 3:45 pm): The Consequences of the Dobbs decision: a look at the impact in women’s health

Session Chair: Dan Grossman

  • ​Jamila Perritt, the CEO of Physicians for Reproductive Health, will be the featured speaker. She will share her perspectives on how Dobbs is affecting people needing abortion care—nationally and specifically in the Southeast—as well as how it’s affecting providers. 
  • Dan Grossman’s work documenting poor quality care since Dobbs (Care Post-Roe Study)
  • Diana Greene Foster discussing the Turnaway Study and her current End of Roe Study 
  • Q&A/Discussion
  • Speakers: Jamila Perritt, CEO of Physicians for Reproductive Health, Dr. Diane Greene Foster, Dr. Dan Grossman

General Session #7 (4:00 pm to 5:00 pm): Panel: Breast Cancer and Maternal Mortality Disparities in African American Women: Connection or Coincidence?

Session Chairs: Andrea Jackson (UCSF), Funmi Olopade

General Session #8 (5:00 pm to 5:45 pm): Improving Diversity in Clinical Trials

Session Chairs: Sara Horton

Advocate: Maimah Karmo 

  • Section 1: Financial Barriers and Insurance Coverage in Clinical Trials 
  • Section 2: Case Study- ISPY 2 Trial and ISPY ACCESS Initiative

Poster Session #3 (5:45 pm to 7:00 pm): Environmental exposures, novel prevention strategies, risk prediction, risk factors

Sunday, November 3, 2024

Poster Session #4 (7:00 am to 8:00 am): Cycle Control, Post-partum weaning, menopause control, modifiable risk factors, Shark Tank Entries

General Session #9 (8:00 am to 8:30 am): Lecture: Science of Endocrine Control Across a Women’s Lifetime

Session Chair: Carol Lange

General Session #10 (8:30 am to 9:45 am): Postpartum Breast Cancer: Opportunities for Improving Treatment and Prevention?

Session Chair: Virginia Borges

Advocate: Lynda Weatherby 

  • Invited Speaker: Traci Lyons, PhD  
  • Presented Abstracts: Postpartum weaning

General Session #11 (10:15 am to 11:15 am): Making Prevention and Holistic Care a Priority in Women’s Health

Session Chair: Dr. Beth Garner

Advocate: Vivian Lee 

  • Pioneer for Prevention Award
  •  Innovation in contraceptive research (Diana Blithe)
  • Secondary Use Indications: what does it take? (Why not promote trials with Global Health Indices) (FDA/Janet Woodcock) 
  • Interdisciplinary Panel: about the underinvestment and health economics in women’s health and prevention broadly, setting the impetus for investment in these types of products

General Session #12 (11:15 am to 12:45 pm): Ideas to Implementation: Incorporating Breast Cancer Prevention into a Holistic Approach to Women's Health

Session Chair: Judges Panel

  • Shark Tank: Panel of biotech/investor/trial leaders judging the translatability of the ideas presented. Prizes awarded.
    • Potential Topics: managing menstrual cycles and pregnancy prevention, postpartum weaning, hormone replacement therapy, and more